Switching on epigenetic therapy
- PMID: 20005793
- DOI: 10.1016/j.cell.2009.11.038
Switching on epigenetic therapy
Abstract
Reversible epigenetic changes that alter gene expression are a characteristic of many cancers and other diseases. Biotech companies are taking note and are starting to develop new drugs to reverse such pathogenic "epimutations."